Pharmacy Report Archives - Page 13 of 151 - Becker's Hospital Review

FDA to review Moderna flu shot | Hackensack Meridian taps CPO | 7 billionaires in US healthcare | NC's PBM pricing law takes effect | 10 systems with strong finances

FDA to review Moderna flu shot & NC PBM law takes effect. February 18, 2026 1. FDA reverses course; agrees to review Moderna flu vaccine Full story 2. Hackensack Meridian taps chief pharmacy officer Full story 3. As hospitals face…

HHS revives 340B rebate idea | What fuels polypharmacy at discharge? | CVS, telehealth co. partner on GLP-1 benefit model | Md. school to launch new PharmD curriculum | Pass rates for 14 pharmacy tech credentials

HHS seeks input on 340B rebate model & CVS to offer GLP-1 benefit model. February 17, 2026 1. Documentation, handoff breakdowns fuel polypharmacy at discharge Full story 2. HHS seeks feedback on 340B rebate model Full story 3. An evolution…

Top 15 schools by NAPLEX pass rates | 12 drugs in shortage | Kaiser pharmacy workers end strike | 3 GLP-1 trends | Sanofi drug gets breakthrough tag

Drug shortages, strike updates and GLP-1 trends top today’s news February 16, 2026 1. Top 15 pharmacy schools by NAPLEX pass rates in 2025 Full story 2. 12 drugs in shortage Full story 3. The CPO role is bigger than…

The 43 meds on TrumpRx | AbbVie sues HHS over negotiated drug prices | 10 systems seeking pharmacy leaders | La. hospital taps pharmacy director | States sue to block $602M CDC cuts

TrumpRx meds, drug pricing lawsuits and leadership shifts top today’s news February 12, 2026 1. The 43 medications on TrumpRx Full story 2. AbbVie sues HHS over Medicare drug price controls Full story 3. How SSM Health, City of Hope…

Bill would force PBMs to divest providers | FDA won't review Moderna flu shot | Amazon Pharmacy grows same-day delivery | Pharmacy leads cancer care at NY, W.Va. systems | FDA: Wegovy pill ad 'misleading'

Senators target PBM-provider ties & FDA declines Moderna flu vaccine review. February 11, 2026 1. Federal bill would require PBMs, insurers to divest providers Full story 2. Amazon Pharmacy to expand same-day delivery to nearly 4.5K cities Full story 3.…

Why systems must integrate pharmacy | CVS, GoodRx join TrumpRx | 74 top Magnet hospitals | Court upholds La. 340B law | FDA fast-tracks U of Wisconsin cell therapy

Why hospital leaders say pharmacy integration is no longer optional. February 10, 2026 1. Why pharmacy integration is no longer optional Full story 2. CVS begins accepting TrumpRx discount cards nationwide Full story 3. See how top health systems are…

Hims & Hers halts Wegovy pill sales | TrumpRx not always cheapest option | Pharmacy workers join Kaiser strike | HHS drops 340B rebate pilot | Forces shaping pharmacy growth this year

GLP-1 disruption, TrumpRx pricing scrutiny and 340B shifts top today’s news February 9, 2026 1. What will drive pharmacy growth in 2026? Full story 2. After industry pressure, Hims & Hers stops selling Wegovy pill Full story 3. Mark Cuban…

Mount Sinai exec talks Trump drug reforms | CVS: 4 drug candidates to watch | Wegovy pill sets record drug launch | Cuban says 'meh' to FTC, Express Scripts settlement | 10 systems seek pharmacy leaders

Regulatory delays, GLP-1 momentum and drug candidates top today’s updates February 5, 2026 1. CVS: 4 drug candidates to watch Full story 2. Why this Mount Sinai leader is cautious toward Trump's drug pricing reforms Full story 3. Cardiology's shifting…

Amgen declines drug withdrawal request | Pharmacists back PBM reforms | Trump addiction plan draws pharmacist push | Breast cancer drug gets priority review | Texas hospital overhauls pharmacy

Drug approval shifts and pharmacist advocacy headline today’s pharma news February 4, 2026 1. Amgen declines FDA request to withdraw rare disease drug Full story 2. Pharmacist groups applaud federal PBM reforms Full story 3. 500+ pharmacy executives. 120+ speakers.…

TrumpRx launch stalled | FDA pauses gene therapy trials | Duke pharmacy looks beyond 'low-hanging fruit' for savings | Anaphylaxis drug approval delayed | Penn State sues insulin makers, PBMs

Regulatory pauses, pricing lawsuits and pharma investment moves shape today’s headlines February 3, 2026 1. The leverage Duke Health is using to grow pharmacy Full story 2. TrumpRx launch delayed Full story 3. Using genetic data to guide medication choices…